Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6373.0000 -89.50 (-1.38%)
NSE Nov 21, 2025 15:31 PM
Volume: 130.8K
 

6373.00
-1.38%
Deven Choksey
Divi’s enters the second half of FY26 with a healthy execution pipeline across Custom Synthesis, supported by multiple projects progressing through validation and expected to commercialize over the next 1–2 years.
Deven Choksey increased Accumulate price target of Divi's Laboratories Ltd. to 6795.0 on 20 Nov, 2025.
More from Divi's Laboratories Ltd.
Recommended